NuVasive, Inc.

418 articles with NuVasive, Inc.

• NuVasive Announces First Quarter 2021 Financial Results

  5/5/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2021.

• NuVasive to Present at Upcoming Investor Conferences

  5/3/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the following virtual investor conferences:

• NuVasive Announces Conference Call and Webcast of First Quarter 2021 Results

  4/19/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2021 earnings results on Wednesday, May 5, 2021, after the close of the market.

• NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

  4/6/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR).

• NuVasive Announces Retirement of Gregory T. Lucier from Board of Directors

  3/25/2021

  Mr. Lucier's commitment to disruptive technology and global scale accelerated Company growth to more than $1 billion in net sales

• NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies

  3/16/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International Spine Study Group Foundation (ISSGF) today announced the continuation of their long-term partnership through the launch of two new clinical studies focused on improving patient outcomes in adult spinal deformity surgery.

• NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results

  2/25/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2020.

• NuVasive Acquires Simplify Medical

  2/24/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).

• NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results

  2/11/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the Company will release its fourth quarter and full year 2020 earnings results on Thursday, February 25, 2021, after the close of the market.

• NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area

  2/8/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the expansion of the Company's Clinical Professional Development and surgeon education program with the planned opening of the NuVasive East Coast Experience Center in Englewood, New Jersey, in third quarter 2021.

• Dr. Siddhartha Kadia to Join NuVasive Board of Directors

  2/1/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Siddhartha Kadia, Ph.D. to the Company's Board of Directors, effective February 1, 2021.

• NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference

  1/7/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 23 rd Annual Needham Virtual Growth Conference on Thursday, January 14, 2021 at 1:15 p.m. ET / 10:15 a.m. P

• NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay

  1/6/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, "Single position circumferential fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion,"

• NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference

  1/4/2021

   NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Chief Executive Officer, J. Christopher Barry will present at the 39 th Annual Virtual J.P. Morgan Healthcare Conference on Wednesd

• NuVasive to Feature its C360 Portfolio at the Cervical Spine Research Society 48th Annual Meeting

  12/7/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a silver level sponsor and feature its new C360™ cervical spine portfolio at the Cervical Spine Research Society (CSRS) 48th Annual Meeting held virtually from December 9-12, 2020.

• NuVasive Unveils C360 Portfolio and Launches New Anterior Cervical Plate

  11/30/2020

   NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the unveiling of its new C360™ cervical spine portfolio, including the commercial launch of the Anterior Cervical Plating (ACP) system

• NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

  11/23/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in one-on-one investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2-3, 2020.

• NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody

  11/18/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Cohere® XLIF®, the first Porous PEEK™ interbody brought to market for use in eXtreme Lateral Interbody Fusion (XLIF) and X360™ surgeries.

• NuVasive's Thoracolumbar Interbody Portfolio Receives First Clearance in the US for the Treatment of Sagittal Deformities

  11/9/2020

   NuVasive, Inc. (NASDAQ: NUVA), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracolumbar interbody portfolio to include the treatment of multi-level sagittal deformities of the thoracolumbar spine.

• NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference

  11/2/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020 at 11:00 a.m. ET/8:00 a.m. PT.